{"id":"https://openalex.org/W2156348241","doi":"https://doi.org/10.1146/annurev.med.58.061705.145053","title":"A Human Monoclonal Antibody Cocktail as a Novel Component of Rabies Postexposure Prophylaxis","display_name":"A Human Monoclonal Antibody Cocktail as a Novel Component of Rabies Postexposure Prophylaxis","alternate_titles":[],"publication_year":2006,"publication_date":"2006-08-03","ids":{"openalex":"https://openalex.org/W2156348241","doi":"https://doi.org/10.1146/annurev.med.58.061705.145053","mag":"2156348241","pmid":"https://pubmed.ncbi.nlm.nih.gov/16886905"},"language":"en","primary_location":{"id":"doi:10.1146/annurev.med.58.061705.145053","doi":"https://doi.org/10.1146/annurev.med.58.061705.145053","is_oa":false,"landing_page_url":"https://doi.org/10.1146/annurev.med.58.061705.145053","pdf_url":null,"source":{"id":"https://openalex.org/S16909082","display_name":"Annual Review of Medicine","issn_l":"0066-4219","issn":["0066-4219","1545-326X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","medline","norway-1","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320373","host_organization_name":"Annual Reviews","host_organization_lineage":["https://openalex.org/P4310320373"],"host_organization_lineage_names":["Annual Reviews"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual Review of Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2156348241"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109232702","display_name":"John de Kruif","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157709","display_name":"Johnson & Johnson (Netherlands)","ror":"https://ror.org/04vkhtf23","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210157709"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John de Kruif","raw_affiliation_strings":["Crucell Holland BV, Leiden, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crucell Holland BV, Leiden, The Netherlands;","institution_ids":["https://openalex.org/I4210157709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111601358","display_name":"Alexander B. H. Bakker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157709","display_name":"Johnson & Johnson (Netherlands)","ror":"https://ror.org/04vkhtf23","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210157709"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexander B.H. Bakker","raw_affiliation_strings":["Crucell Holland BV, Leiden, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crucell Holland BV, Leiden, The Netherlands;","institution_ids":["https://openalex.org/I4210157709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054816201","display_name":"Wilfred E. Marissen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157709","display_name":"Johnson & Johnson (Netherlands)","ror":"https://ror.org/04vkhtf23","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210157709"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wilfred E. Marissen","raw_affiliation_strings":["Crucell Holland BV, Leiden, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crucell Holland BV, Leiden, The Netherlands;","institution_ids":["https://openalex.org/I4210157709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053316803","display_name":"R. Arjen Kramer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157709","display_name":"Johnson & Johnson (Netherlands)","ror":"https://ror.org/04vkhtf23","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210157709"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Arjen Kramer","raw_affiliation_strings":["Crucell Holland BV, Leiden, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crucell Holland BV, Leiden, The Netherlands;","institution_ids":["https://openalex.org/I4210157709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079896090","display_name":"Mark Throsby","orcid":"https://orcid.org/0000-0003-1352-3946","observed_orcids":["https://orcid.org/0000-0003-1352-3946"]},"institutions":[{"id":"https://openalex.org/I4210157709","display_name":"Johnson & Johnson (Netherlands)","ror":"https://ror.org/04vkhtf23","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210157709"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark Throsby","raw_affiliation_strings":["Crucell Holland BV, Leiden, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crucell Holland BV, Leiden, The Netherlands;","institution_ids":["https://openalex.org/I4210157709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012181714","display_name":"Charles E. Rupprecht","orcid":"https://orcid.org/0000-0002-8010-0743","observed_orcids":["https://orcid.org/0000-0002-8010-0743"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charles E. Rupprecht","raw_affiliation_strings":["Rabies Section, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rabies Section, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333","institution_ids":["https://openalex.org/I1289490764"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109872740","display_name":"Jaap Goudsmit","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157709","display_name":"Johnson & Johnson (Netherlands)","ror":"https://ror.org/04vkhtf23","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210157709"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jaap Goudsmit","raw_affiliation_strings":["Crucell Holland BV, Leiden, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crucell Holland BV, Leiden, The Netherlands;","institution_ids":["https://openalex.org/I4210157709"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7694,"has_fulltext":false,"cited_by_count":91,"citation_normalized_percentile":{"value":0.57948718,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"58","issue":"1","first_page":"359","last_page":"368"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11780","display_name":"Rabies epidemiology and control","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11780","display_name":"Rabies epidemiology and control","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11112","display_name":"Viral Infections and Immunology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rabies","display_name":"rabies","score":0.7549999952316284},{"id":"https://openalex.org/keywords/rabies-post-exposure-prophylaxis","display_name":"rabies post-exposure prophylaxis","score":0.8989999890327454},{"id":"https://openalex.org/keywords/human-monoclonal-antibodies","display_name":"human monoclonal antibodies","score":0.8939999938011169},{"id":"https://openalex.org/keywords/rabies-immunoglobulin","display_name":"rabies immunoglobulin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/rabies-vaccine","display_name":"rabies vaccine","score":0.9409999847412109},{"id":"https://openalex.org/keywords/monoclonal-antibody-development","display_name":"monoclonal antibody development","score":0.7170000076293945},{"id":"https://openalex.org/keywords/rabies-virus","display_name":"rabies virus","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C2776849203","wikidata":"https://www.wikidata.org/wiki/Q39222","display_name":"Rabies","level":2,"score":0.9037138223648071},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.8003254532814026},{"id":"https://openalex.org/C2777961786","wikidata":"https://www.wikidata.org/wiki/Q698976","display_name":"Rabies virus","level":3,"score":0.7321826219558716},{"id":"https://openalex.org/C956191","wikidata":"https://www.wikidata.org/wiki/Q930144","display_name":"Polyclonal antibodies","level":3,"score":0.7035174369812012},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6766881346702576},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.532747745513916},{"id":"https://openalex.org/C2779811178","wikidata":"https://www.wikidata.org/wiki/Q940434","display_name":"Lyssavirus","level":5,"score":0.5202844738960266},{"id":"https://openalex.org/C2780674857","wikidata":"https://www.wikidata.org/wiki/Q4007169","display_name":"Rabies vaccine","level":4,"score":0.47736239433288574},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.4758327007293701},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.47501978278160095},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40384232997894287},{"id":"https://openalex.org/C2777974785","wikidata":"https://www.wikidata.org/wiki/Q1356983","display_name":"Rhabdoviridae","level":4,"score":0.34492361545562744}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007136","descriptor_name":"Immunoglobulins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011818","descriptor_name":"Rabies","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D011820","descriptor_name":"Rabies virus","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1146/annurev.med.58.061705.145053","doi":"https://doi.org/10.1146/annurev.med.58.061705.145053","is_oa":false,"landing_page_url":"https://doi.org/10.1146/annurev.med.58.061705.145053","pdf_url":null,"source":{"id":"https://openalex.org/S16909082","display_name":"Annual Review of Medicine","issn_l":"0066-4219","issn":["0066-4219","1545-326X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","medline","norway-1","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320373","host_organization_name":"Annual Reviews","host_organization_lineage":["https://openalex.org/P4310320373"],"host_organization_lineage_names":["Annual Reviews"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual Review of Medicine","raw_type":"journal-article"},{"id":"pmid:16886905","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16886905","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual review of medicine","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/638cad23-2c18-49bb-9200-a0144471c8fe","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/638cad23-2c18-49bb-9200-a0144471c8fe","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"de Kruif, J, Bakker, A B H, Marissen, W E, Kramer, R A, Throsby, M, Rupprecht, C E & Goudsmit, J 2007, 'A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis', Annual review of medicine, vol. 58, pp. 359-368. https://doi.org/10.1146/annurev.med.58.061705.145053","raw_type":"info:eu-repo/semantics/review"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/23537da5-bcc1-461e-ab58-f732628e7eeb","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/a-human-monoclonal-antibody-cocktail-as-a-novel-component-of-rabies-postexposure-prophylaxis(23537da5-bcc1-461e-ab58-f732628e7eeb).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Annual review of medicine, 58, 359 - 368. Annual Reviews Inc.","raw_type":"info:eu-repo/semantics/other"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W133106856","https://openalex.org/W168457044","https://openalex.org/W1568052653","https://openalex.org/W1629534529","https://openalex.org/W1890717569","https://openalex.org/W1923669997","https://openalex.org/W1968878148","https://openalex.org/W1971456299","https://openalex.org/W1990777888","https://openalex.org/W1992274022","https://openalex.org/W2002563971","https://openalex.org/W2013757167","https://openalex.org/W2030531413","https://openalex.org/W2031152984","https://openalex.org/W2038043114","https://openalex.org/W2058339265","https://openalex.org/W2060363530","https://openalex.org/W2061142243","https://openalex.org/W2063887342","https://openalex.org/W2079322295","https://openalex.org/W2089887554","https://openalex.org/W2095080431","https://openalex.org/W2109715765","https://openalex.org/W2115767265","https://openalex.org/W2117458024","https://openalex.org/W2119479524","https://openalex.org/W2120320243","https://openalex.org/W2123301882","https://openalex.org/W2136726332","https://openalex.org/W2138186489","https://openalex.org/W2139135964","https://openalex.org/W2153123202","https://openalex.org/W2155130452","https://openalex.org/W2158246189","https://openalex.org/W2166916380","https://openalex.org/W2414194365"],"related_works":["https://openalex.org/W2166916380","https://openalex.org/W2019839577","https://openalex.org/W4404764879","https://openalex.org/W4281744232","https://openalex.org/W2105926799","https://openalex.org/W2298668359","https://openalex.org/W4213004539","https://openalex.org/W2768225533","https://openalex.org/W3197728610","https://openalex.org/W2902085983"],"abstract_inverted_index":{"The":[0],"currently":[1,63],"recommended":[2],"treatment":[3],"for":[4,42,53],"individuals":[5],"exposed":[6],"to":[7,29,62],"rabies":[8,15,18],"virus":[9],"is":[10],"the":[11,26,50],"combined":[12],"administration":[13],"of":[14,32,35,55],"vaccine":[16],"and":[17,57],"immune":[19],"globulin":[20],"(RIG).":[21],"This":[22],"review":[23],"sets":[24],"out":[25],"criteria":[27],"used":[28,64],"guide":[30],"development":[31,54],"a":[33,40,48],"cocktail":[34],"human":[36],"monoclonal":[37,59],"antibodies":[38],"as":[39,47],"replacement":[41],"RIG.":[43],"Using":[44],"this":[45],"process":[46],"model,":[49],"general":[51],"requirements":[52],"safe":[56],"efficacious":[58],"antibody":[60],"alternatives":[61],"polyclonal":[65],"serum":[66],"products":[67],"are":[68],"discussed.":[69]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2156348241","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
